Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Ditropan XL shows favorable efficacy/side effect profile in phase III study

July 8, 1998

Blockade of angiotensin II receptor reduces radiation-induced renal and lung injury

July 7, 1998

P&U characterizes dual inhibitor of both 5alpha-reductase isozymes

July 3, 1998

Positive preliminary results reported for extended-use clinical trial of RenaGel

July 3, 1998

Nippon Shinyaku discovers new treatment for urinary incontinence

June 12, 1998

ET antagonist protects against ciclosporin-induced nephrotoxicity in rats

June 11, 1998

New and established treatments for BPH reviewed at AUA

June 10, 1998

Urinary reflux product enters phase III

June 9, 1998

Dornier's BPH device approved by FDA

June 9, 1998

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

June 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...